Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot feasibility study of 20% vs 5% human albumin for fluid bolus therapy in critically ill adults
2016-001940-20Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human albumin in hypovolemia (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Amount of resuscitation fluid administered over the first 48 hours in intensive care. Started Oct 2016; status: completed.
02
Drugs
human albumin
03
Conditions
hypovolemia
Beyond the preview
Go deeper on 2016-001940-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001940-20.